Pathophysiology of AD Treatments

Andrew Blauvelt, MD, provides an overview of the significance of JAK/Stat pathway inhibition in targeting the pathophysiology of atopic dermatology (AD).

Related Content:

Long-term Use and Safety of JAK Inhibitors and Evaluating Efficacy Outcomes in Atopic DermatitisSpecial ReportsDermatologyAtopic Dermatitis

Link Identified Between Obesity, Inflammatory Skin Diseases Such as Psoriasis

Study Highlights Wound Closure Techniques Following Wide Excision for HS

Study Finds Chronic Psychological Stress Triggers Skin Aging